We don't cater to customers in UAE, we only ship internationally.

Sipmax International
  • STELARA 90 mg Injection
  • STELARA 90 mg Injection

STELARA 90 mg Injection

STELARA 90 mg Injection STELARA contains Ustekinumab, a human IgG1kappa monoclonal antibody that targets the p40 subunit shared by interleukin-12 (IL-12) and interleukin-23 (IL-23) cytokines. By preventing their binding to the IL-12Rβ1 receptor complex on T cells and natural killer cells, ustekinumab disrupts inflammatory signaling cascades and downstream immune responses. This subcutaneous formulation is indicated for maintenance therapy in adult patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.

Read more
WhatsApp Telegram Email
Brand STELARA
Storage Temperature Store in a refrigerator at 2°C to 8°C; keep in original carton to protect from light; do not freeze; do not shake
Prescription Needed Yes
Composition Ustekinumab
Strength 90 mg
Form Solution for Injection
Pack Size 1 Pre-filled Syringe
Packaging Single-dose pre-filled syringe
Manufacturer Janssen Biotech, Inc. (Johnson & Johnson)

STELARA 90 mg Injection

STELARA 90 mg Injection STELARA contains Ustekinumab, a human IgG1kappa monoclonal antibody that targets the p40 subunit shared by interleukin-12 (IL-12) and interleukin-23 (IL-23) cytokines. By preventing their binding to the IL-12Rβ1 receptor complex on T cells and natural killer cells, ustekinumab disrupts inflammatory signaling cascades and downstream immune responses. This subcutaneous formulation is indicated for maintenance therapy in adult patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.

Related Products